Proteomics screens have identified PIR-1 as a major component of C. elegans Dicer complexes (Duchaine et al., 2006). PIR-1 is strongly conserved in metazoans and is related to the phosphatase domain of the mRNA capping enzyme. Human PIR1 sequentially removes the 5''-end g- and b-phosphates from triphosphorylated RNA molecules in vitro, leaving a 5''-monophosphate (Yuan et al., 1998; Deshpande et al., 1999). A recent study has established human PIR1 as a
p53 transcription factor target, and suggests that changes in PIR1 levels affect cell proliferation (Helin et al., 2008). C. elegans
pir-1 deletion mutants are sterile and arrest development as young adults. Their germline is smaller than normal and exhibits no signs of oogenesis. Malformed vulvae and occasional bursting also suggest a role in somatic development. Despite the severity of the phenotype, these animals remain active for the duration of a normal life span. These defects are fully rescued by GFP and 3xFlag fusions of
pir-1. PIR-1::GFP is expressed in all tissues throughout development where it localizes in nuclei. Immunoprecipitation of these functional PIR-1 fusion proteins confirmed Dicer as a robust interactor and, through a combination of Western blotting and MudPIT proteomics, led to the identification of several other RNAi-related interactors. These novel interactions are now under further investigation. Northern blotting and deep sequencing experiments suggest that arrested
pir-1 animals are wild-type for all known endogenous small RNA pathways, including Dicer-dependent pathways such as miRNA biogenesis. Exogenously triggered RNAi is also unaffected in
pir-1 mutants, as exo-siRNAs can be detected and are accompanied by downregulation of their target mRNAs. Furthermore, these small RNAs have the same 5'' phosphorylation status as those of wild-type animals. Current efforts are centered on exploring whether and how PIR-1 functions in concert with Dicer to promote development, perhaps through a hitherto uncharacterized small RNA pathway.